
1. j travel med. 2013 jul-aug;20(4):232-6. doi: 10.1111/jtm.12039. epub 2013 may 15.

acute hepatitis israeli travelers.

lachish t(1), tandlich m, schwartz e.

author information: 
(1)the infectious diseases unit, shaare-zedek medical center, jerusalem, israel.

background: acute hepatitis well-described cause morbidity sporadic
mortality travelers. data regarding epidemiology hepatitis travelers
are lacking. aim study describe epidemiology acute viral
hepatitis among travelers returning tropical countries, particular
attention enterically transmitted hepatitis.
methods: study prospective observational study ill-returned
travelers presented two travel medicine clinics israel the
years 1997 2012. data patients acute hepatitis summarized. 
travelers included, immigrants foreign workers excluded.
results: among 4,970 israeli travelers seen period, 49 (1%) 
were diagnosed acute hepatitis. among them, hepatitis e virus (hev) 
etiology 19 (39%) cases hepatitis virus (hav) etiology 13
(27%) cases, demonstrating 65% cases due enterically
transmitted hepatitis. acquiring acute hepatitis b (two cases) acute hepatitis
c (one case) uncommon (6.1%). 27% cases, diagnosis was
determined. fifty-five percent cases imported indian
subcontinent, predominance hev infection (84%). significant male
predominance seen groups regardless etiology. pre-travel
consultation documented 7% vaccine preventable
hepatitis (hepatitis & b) compared 89% hepatitis e.
conclusions: enterically transmitted hepatitis main causes viral
hepatitis among travelers. hev emerging disease become most
common hepatitis among israeli travelers. although efficacious vaccine has
been developed, licensed hev vaccine yet available. although hepatitis a
vaccine highly efficacious, safe, easily available, stable
number hav cases.

Â© 2013 international society travel medicine.

doi: 10.1111/jtm.12039 
pmid: 23809073  [indexed medline]

